http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017025011-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e04a9c30b01a6909696dc92e883f241c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| filingDate | 2015-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_055a2013c4a3ab4642937d8b6cec9df5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56deb71c7a9389212cba88a5569fe1f5 |
| publicationDate | 2017-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2017025011-A |
| titleOfInvention | Anti-BMP9 antibody |
| abstract | An anti-BMP9 monoclonal antibody or an antibody fragment thereof that binds to human bone morphogenetic protein (BMP) 9 is provided. [MEANS FOR SOLVING PROBLEMS] One antibody selected from the following (a) and (b), or binding to human BMP9 in competition with the antibody, wherein the binding dissociation constant to human BMP9 is 1 × 10 −10 mol / L or less. A certain monoclonal antibody or the antibody fragment. It binds to an epitope to which one antibody selected from the following (a) or (b) binds. A monoclonal antibody or antibody fragment which is a gene recombinant antibody selected from a human chimeric antibody, a humanized antibody or a human antibody. (A) An antibody comprising three heavy chain determining regions (CDRs) each containing an H chain of an antibody containing a specific amino acid sequence and an L chain of an antibody containing a specific amino acid sequence (b) A specification different from the above sequence Antibody comprising the heavy chain variable region of an antibody comprising the amino acid sequence of and comprising the light chain variable region of an antibody comprising a specific amino acid sequence |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019117208-A1 |
| priorityDate | 2015-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 439.